Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?
Shirley R. KuhlmannEVP and General Counsel2024-06-0324,300$32.55
Shirley R. KuhlmannEVP and General Counsel2024-06-03700$33.22
Colleen TupperEVP Chief Financial Officer2024-05-2819,710$34.22
Scott DreyerEVP Chief Commercial Officer2024-05-2456,807$33.98
Scott DreyerEVP Chief Commercial Officer2024-05-2423,791$24.03
Scott DreyerEVP Chief Commercial Officer2024-05-2351,209$33.82
Scott DreyerEVP Chief Commercial Officer2024-05-2351,209$24.03
Garen G. BohlinDirector2024-05-1428,985$32.30
Garen G. BohlinDirector2024-05-1428,985$5.73
Thomas B. SmithEVP and Chief Medical Officer2024-02-29995$36.76

1 of 4

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?
David Hirsch19.68%6,438,798$205.27MInsider
Blackrock Inc17.93%5,865,899$187.00MInstitution
Longitude Capital Partners LLC17.25%5,643,684$179.92MInsider
Skyline Venture Partners V LP15.59%5,099,832$162.58MInsider
Eventide Asset Management LLC8.05%2,634,041$83.97MInstitution
Pacer Advisors Inc7.91%2,586,828$82.47MInstitution
Vanguard Group Inc7.12%2,330,728$74.30MInstitution
Yasunori Kaneko6.57%2,150,186$68.55MInsider
Patrick J. Heron5.77%1,887,332$60.17MInsider
Frazier Healthcare Vi LP5.77%1,887,332$60.17MInsider

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL59.01%40.99%Net SellingNet Selling
IRWD73.02%26.98%Net SellingNet Selling
CRON11.49%48.39%Net SellingNet Selling
PCRX68.67%31.33%Net SellingNet Selling
ANIP22.61%77.39%Net SellingNet Selling

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 121.75% institutional shareholders, 84.57% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 19.68% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $205.72M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.